<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02604888</url>
  </required_header>
  <id_info>
    <org_study_id>MEXIS-ALOPECIA AREATA-2015</org_study_id>
    <nct_id>NCT02604888</nct_id>
  </id_info>
  <brief_title>Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females</brief_title>
  <acronym>MEXISAREATA</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Mexis George</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mexis George</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the Hair Loss Prevention Lotion named
      MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Alopecia Areata.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study verifies whether the tested product has any efficacy in the treatment of Alopecia
      Areata.

        -  The evaluated product (Hair Loss prevention Lotion) is called: MEXIS, MPAF, M6S PATENT.

        -  20 volunteers both men and women suffering from hair loss both in parties and over the
           entire scalp with age between 18 and 70 years will be selected for this test .

        -  Samples of the product have been applied following their usual use: as they are.

        -  On the selecting volunteers will be used:

      A polarized light video-camera to check the redness of the scalp and to have a picture of
      hair and scalp.

        -  Volunteers will also be asked about:

        -  Fluffiness

        -  Sheen

        -  Itching

        -  Presence of scales on scalp

        -  Oily hair

        -  Product's acceptability

        -  The readings will be taken at 0 time (basal value), after 15 days (t15), 30 days (t30),
           45 days (t45), 45 days (t45), 60 days (t60) and 90 days (t90) by the experimenter in the
           medical studio. Then they analyzed and reported in a graph.

        -  Summarizing tables and graphs of the data will be taken during experimentation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of the Density of the Hair measured with a camera</measure>
    <time_frame>baseline and 180 days</time_frame>
    <description>Change on the total amount of head's hair</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of the Amount of Hair Loss</measure>
    <time_frame>baseline and 180 days</time_frame>
    <description>Change on the amount of hair fallen per day</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Alopecia Areata</condition>
  <arm_group>
    <arm_group_label>Volunteers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>20 volunteers both men and women with an age between 18 and 70 years suffering from Alopecia Areata in several types apply on the scalp drops of the MEXIS/M6S PATENT - lotion against Alopecia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MEXIS/M6S Patent - lotion against alopecia</intervention_name>
    <description>For greatest problems 20 drops on the scalp per day for 6 months. For minor problems 10 drops on the scalp three times per week for 6 months.</description>
    <arm_group_label>Volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Good state of general health

          -  Suffering from Alopecia Areata

          -  No pharmacological treatment in progress

          -  Promise not to change the usual daily routine

          -  No atopy in the anamnesis

        Exclusion Criteria:

          -  Illness

          -  Good state of hair

          -  Pharmacological treatment in progress

          -  Denial of the continuance of the usual daily routine

          -  Atopy in the anamnesis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markos Papakonstantis, Monitor</last_name>
    <role>Study Chair</role>
    <affiliation>401 General Military Hospital of Athens, Dermatology clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandy Matzakoni, Controller</last_name>
    <phone_ext>0030</phone_ext>
    <email>info@mexis.gr</email>
  </overall_contact>
  <location>
    <facility>
      <name>George Mexis</name>
      <address>
        <city>Athens</city>
        <zip>11253</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matzakonis Sandy, Supervisor</last_name>
      <phone>2108623547</phone>
      <phone_ext>0030</phone_ext>
      <email>info@mexis.gr</email>
    </contact>
    <investigator>
      <last_name>Markos Papakonstantis, Controller</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2015</study_first_submitted>
  <study_first_submitted_qc>November 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2015</study_first_posted>
  <last_update_submitted>January 3, 2017</last_update_submitted>
  <last_update_submitted_qc>January 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Baldness</keyword>
  <keyword>Alopecia Areata</keyword>
  <keyword>Alopecia</keyword>
  <keyword>Hair loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alopecia</mesh_term>
    <mesh_term>Alopecia Areata</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

